What Researchers Did
Researchers retrospectively compared hearing outcomes in 63 adult patients with sudden sensorineural hearing loss treated with either corticosteroids alone or corticosteroids combined with hyperbaric oxygen therapy.
What They Found
The average hearing gain was 12.5 dB HL in patients receiving corticosteroids plus hyperbaric oxygen therapy (HBOT) and 14.1 dB HL in those receiving corticosteroids alone. Successful treatment (complete recovery or marked improvement) was observed in 27.8% of the HBOT group and 25.5% of the steroid-only group, with no statistically significant difference between the groups.
What This Means for Canadian Patients
For Canadian patients experiencing sudden sensorineural hearing loss, this study suggests that adding hyperbaric oxygen therapy to standard corticosteroid treatment may not offer additional hearing benefits. Patients should discuss treatment options with their audiologist or ENT specialist to determine the most effective approach for their specific condition.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian participants or researchers.
Study Limitations
This was a retrospective study, which inherently limits the reliability of its findings compared to a prospective, controlled, and randomized study.